Skip to content
healthcare.dev

Hydralazine Hydrochloride

NDC 67877-291, Hydralazine Hydrochloride, tablet, from Ascend Laboratories, LLC.

Product NDC
67877-291
Status
Listed
Labeler
Ascend Laboratories, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA200737
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67877-291 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDRALAZINE HYDROCHLORIDE50 mg/1

Pharmacologic classes

Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]

Package NDCNDC-11Package
67877-291-0167877029101100 TABLET in 1 BOTTLE (67877-291-01)
67877-291-0567877029105500 TABLET in 1 BOTTLE (67877-291-05)
67877-291-10678770291101000 TABLET in 1 BOTTLE (67877-291-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e7bfec3d-5222-4a26-8f99-6c2a28e14aa6

Use it

Look up 67877-291 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67877-291 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67877-291. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.